Fibronostics Employee Directory

Hospitals and Health CareLouisiana, United States11-50 Employees

Fibronostics develops algorithm-driven diagnostic tools for non-invasive disease assessment, with a primary focus on liver disease existence and progression and extending to other chronic conditions. Its LIVERFASt product line supports early detection and monitoring of non-alcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), addressing cases that screening with limited sensitivity may miss. The HealthFACTR platform estimates a patient’s risk for coronary heart disease, stroke, diabetes, and fatty liver disease, and translates that risk into actionable recommendations to guide clinical decision-making. Based in New Orleans, Louisiana, Fibronostics operates in the Hospitals and Health Care sector, serving healthcare providers who require non-invasive tools to identify disease presence and manage risk. Its offerings target clinicians and care teams seeking timely, evidence-based guidance when traditional diagnostics are invasive, costly, or risky. In 2023, the company announced a collaboration with Stone Diagnostics, reflecting an effort to broaden the adoption of its diagnostic solutions.

Sign up for free to view info

Company overview Email format